Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Fluad and Agriflu vs Fluzone in Children
NCT01346592Phase 3Completed
- Sponsor
- Novartis
- Start
- Apr 2011
- Primary completion
- Jul 2012
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 5
01
Overview
A Phase 3 trial of influenza vaccine (surface antigen, inactivated, adjuvanted), agriflu in influenza, sponsored by Novartis. Started Apr 2011; status: completed.
02
Drugs
influenza vaccine (surface antigen, inactivated, adjuvanted)agriflu
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01346592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01346592.